Citigroup’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $267M | Sell |
|
|||||
|
2025
Q1 | $304M | Buy |
|
|||||
|
2024
Q4 | $186M | Sell |
|
|||||
|
2024
Q3 | $274M | Buy |
|
|||||
|
2024
Q2 | $225M | Buy |
|
|||||
|
2024
Q1 | $167M | Sell |
|
|||||
|
2023
Q4 | $185M | Buy |
|
|||||
|
2023
Q3 | $155M | Sell |
|
|||||
|
2023
Q2 | $163M | Buy |
|
|||||
|
2023
Q1 | $134M | Sell |
|
|||||
|
2022
Q4 | $140M | Buy |
|
|||||
|
2022
Q3 | $140M | Buy |
|
|||||
|
2022
Q2 | $136M | Sell |
|
|||||
|
2022
Q1 | $135M | Sell |
|
|||||
|
2021
Q4 | $145M | Buy |
|
|||||
|
2021
Q3 | $105M | Sell |
|
|||||
|
2021
Q2 | $141M | Buy |
|
|||||
|
2021
Q1 | $137M | Buy |
|
|||||
|
2020
Q4 | $120M | Buy |
|
|||||
|
2020
Q3 | $90.9M | Sell |
|
|||||
|
2020
Q2 | $106M | Buy |
|
|||||
|
2020
Q1 | $57M | Buy |
|
|||||
|
2019
Q4 | $51.1M | Sell |
|
|||||
|
2019
Q3 | $54.2M | Sell |
|
|||||
|
2019
Q2 | $68.6M | Buy |
|
|||||
|
2019
Q1 | $46.9M | Buy |
|
|||||
|
2018
Q4 | $35.7M | Buy |
|
|||||
|
2018
Q3 | $33.4M | Buy |
|
|||||
|
2018
Q2 | $17M | Sell |
|
|||||
|
2018
Q1 | $30.3M | Buy |
|
|||||
|
2017
Q4 | $23.8M | Buy |
|
|||||
|
2017
Q3 | $21M | Sell |
|
|||||
|
2017
Q2 | $23.9M | Buy |
|
|||||
|
2017
Q1 | $19.8M | Sell |
|
|||||
|
2016
Q4 | $15.8M | Buy |
|
|||||
|
2016
Q3 | $5.99M | Sell |
|
|||||
|
2016
Q2 | $6.78M | Sell |
|
|||||
|
2016
Q1 | $8.2M | Buy |
|
|||||
|
2015
Q4 | $9.28M | Sell |
|
|||||
|
2015
Q3 | $13.7M | Sell |
|
|||||
|
2015
Q2 | $17.3M | Sell |
|
|||||
|
2015
Q1 | $21.1M | Sell |
|
|||||
|
2014
Q4 | $21.6M | Buy |
|
|||||
|
2014
Q3 | $18.3M | Sell |
|
|||||
|
2014
Q2 | $36.3M | Buy |
|
|||||
|
2014
Q1 | $12.9M | Sell |
|
|||||
|
2013
Q4 | $14.7M | Buy |
|
|||||
|
2013
Q3 | $13.5M | Buy |
|
|||||
|
2013
Q2 | $9.18M | Buy |
|